Показано 0 из 0
Дата |
---|
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
1.65
|
1.66
|
1.76
|
1.3601
|
1.88
|
1.75
|
|
|
49 467 207.27
|
133 039.00
|
1.30
|
1.40
|
1.357
|
1.31
|
1.39
|
1.36
|
|
|
49 872.61
|
88.00
|
1.36
|
1.49
|
1.36
|
1.30
|
1.36
|
1.3444
|
|
|
45 250.05
|
130.00
|
1.31
|
1.44
|
1.41
|
1.31
|
1.44
|
1.37
|
|
|
27 734.57
|
90.00
|
1.35
|
1.45
|
1.42
|
1.37
|
1.4498
|
1.4101
|
|
|
28 545.83
|
76.00
|
1.25
|
1.40
|
1.32
|
1.32
|
1.38
|
1.38
|
|
|
37 419.35
|
88.00
|
1.30
|
1.45
|
1.39
|
1.30
|
1.44
|
1.30
|
|
|
48 683.80
|
185.00
|
1.30
|
1.41
|
1.4499
|
1.38
|
1.48
|
1.41
|
|
|
34 539.11
|
103.00
|
1.31
|
1.60
|
1.30
|
1.30
|
1.40
|
1.36
|
|
|
18 994.89
|
74.00
|
1.05
|
1.31
|
1.38
|
1.32
|
1.45
|
1.32
|
|
|
8 028.99
|
81.00
|
Context Therapeutics Inc. is a women’s oncology company developing advanced small molecule and immunotherapy treatments to transform care for hormone-driven breast and gynecological cancers.